NeuroSigma, Inc
Industry
- Medical Devices
Other Names/Subsidiaries
- NSVascular, Inc.
See more in Biomedtracker
Latest on NeuroSigma, Inc
Medtech Insight
• By Reed Miller
Deals In September BI, Inflammasome Ally In $160m Retinal Diseases Collaboration Boehringer Ingelheim International GmbH and Inflammasome Therapeutics Inc. agreed to co-develop up to three candida
Medtech Insight
• By Reed Miller
NeuroSigma Inc. ’s Monarch external trigeminal nerve stimulation (eTNS) system is the first device specifically cleared by the US Food & Drug Administration for treating attention deficit hyperactivit
Medtech Insight
The field of neuromodulation, or the introduction of nerve stimulation into the central nervous system, peripheral nervous system, autonomic nervous system, or deep cell nuclei of the brain via an imp